NEOGEN CORP
Company Stats
- Market Cap
- $2.8B
- as of Sep 30, 2026
- Enterprise Value
- $3.4B
- Shares Outstanding
- 218.3M
- Free Float
- 99.4%
Income Statement
- Revenue
- $870.4M
- Operating Income
- -$21.6M
- Net Income
- -$7.9M
- EBITDA
- $94.7M
- Revenue Growth, 3Y
- 1.9%
- FCF Margin, 3Y Avg
- -3.3%
- FCF Margin, Worst Year
- -8.2%
Cash Flow
- Free Cash Flow
- $31.9M
- FCF Yield
- 1.1%
- Owner FCF Yield
- 0.7%
Balance Sheet
- Cash & Equivalents
- $185.5M
- Total Debt
- $800.0M
- Net Debt
- $614.5M
- Net Debt / EBITDA
- 6.49x
- EV / EBITDA
- 35.96x
Returns & Capital
- SBC, 3Y Avg
- $14.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2026 | $870.4M | $31.9M | 3.7% |
| FY2025 | $894.7M | -$46.4M | -5.2% |
| FY2024 | $924.2M | -$76.1M | -8.2% |
| FY2023 | $822.4M | -$24.7M | -3.0% |
| FY2022 | $527.2M | $43.6M | 8.3% |
Annual filing data through FY ended May 31, 2026; shares and float as of November 7, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back